Rituximab for Anti-cytokine Autoantibody-Associated Diseases

Clinical trial NCT01842386 · COMPLETED

Trial details

NCT number: NCT01842386
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Alveolar Proteinosis (PAP)Severe Mucocutaneous Candidiasis

Start date: 2014-04-29
Primary completion: 2021-05-06
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.